Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q54069097)
Watch
English
The MYSTIC (meropenem yearly susceptibility test information collection) programme.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
title
The MYSTIC (meropenem yearly susceptibility test information collection) programme.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
main subject
meropenem
1 reference
based on heuristic
inferred from title
author name string
Turner PJ
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
Greenhalgh JM
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
Edwards JR
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
McKellar J
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
publication date
1 October 1999
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
published in
International Journal of Antimicrobial Agents
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
volume
13
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
page(s)
117-125
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
cites work
Antibiotic resistance and production of extended-spectrum beta-lactamases amongst Klebsiella spp. from intensive care units in Europe
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Emergence of a carbapenem-resistant Klebsiella pneumoniae
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Appearance of IMP-1 metallo-beta-lactamase in Europe.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meropenem: a microbiological overview
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro studies of meropenem
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activity of imipenem on aerobic bacteria.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In-vitro antibacterial activity of imipenem compared with four other beta-lactam antibiotics (ceftazidime, cefotaxime, piperacillin and azlocillin) against 828 separate clinical isolates from a Portuguese hospital
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patients. Meropenem Serious Infection Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Re
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Equivalent efficacies of meropenem and ceftazidime as empirical monotherapy of febrile neutropenic patients. The Meropenem Study Group of Leuven, London and Nijmegen
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical evaluation of meropenem versus ceftazidime for the treatment of Pseudomonas spp. infections in cystic fibrosis patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of carbapenems and other antibiotics for pulmonary infections in patients with cystic fibrosis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vitro activity and stability against novel beta-lactamases of investigational beta-lactams (cefepime, cefpirome, flomoxef, SCE2787 and piperacillin plus tazobactam) in comparison with established compounds (cefotaxime, latamoxef and piperacillin)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interactions of tazobactam and clavulanate with inducibly- and constitutively-expressed Class I beta-lactamases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bacteremia due to fluoroquinolone-resistant Escherichia coli in two immunocompromised patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to beta-lactam antibiotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0924-8579%2899%2900115-6
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0924-8579(99)00115-6
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
PubMed publication ID
10595570
1 reference
stated in
Europe PubMed Central
PubMed publication ID
10595570
retrieved
24 May 2018
reference URL
http://europepmc.org/abstract/MED/10595570
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit